Shares of DaVita Inc. DVA slid 0.47% to $149.66 Friday, on what proved to be an all-around positive trading session for the ...

DENVER, Nov. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, ...

(Reuters) -Dialysis firm DaVita reported third-quarter profit that missed Wall Street estimates on Tuesday, hurt by high patient care costs. Shares of the company were down 7.1% at $147 after the bell ...

At this time, we would like to welcome everyone to the DaVita third quarter 2024 earnings call. [Operator instructions] Thank ...

Shares of DaVita Inc. DVA rallied 2.24% to $150.37 Thursday, on what proved to be an all-around mixed trading session for the ...

Dialysis specialist DaVita (NYSE: DVA) had quite the Wednesday to forget, as investors sold out of its stock following the ...

DaVita Inc. (NYSE:DVA – Get Free Report)’s stock price gapped down prior to trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at ...

Analyst Joanna Gajuk of Bank of America Securities reiterated a Sell rating on DaVita (DVA – Research Report), with a price target of ...

Plus: Warning signs for Lauren Boebert. An illuminating exit poll. Andrew Boesenecker seeks to replace Jennifer Bacon.

If anything, Tuesday's defeat — and it stung — is motiving the former DaVita CEO to continue the conversation. He says ...

In a report released today, Ryan Langston from TD Cowen maintained a Hold rating on DaVita (DVA – Research Report), with a price target of $150.00. The company’s shares closed yesterday at $158.31.

The DaVita Health Tour is back on the road for 2024 providing free health screenings and chronic disease education to ...